2017 annual financial data
Sutro Biopharma 2017 Operating cash flow margin
Sutro Biopharma 2017 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was -71.65%.
Operating income was -19,272,000 USD and net income was -19,688,000 USD.
Operating cash flow was -37,074,000 USD.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 51,741,000 USD
- Operating income
- -19,272,000 USD
- Net income
- -19,688,000 USD
- Operating cash flow
- -37,074,000 USD